Qianying Liu
Luzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.
Journal: Cell
Published: April 30, 2024
Dynamic molecular architecture and substrate recruitment of cullin3-RING E3 ligase CRL3KBTBD2.
Journal: Nature structural & molecular biology
Published: March 17, 2023
Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Journal: Journal of virology
Published: August 04, 2022
Asymmetric pendrin homodimer reveals its molecular mechanism as anion exchanger.
Journal: Nature communications
Published: May 27, 2022
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies.
Journal: Cell discovery
Published: March 18, 2022
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Journal: Protein & cell
Published: November 20, 2020
Mequindox induces apoptosis, DNA damage, and carcinogenicity in Wistar rats.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: August 24, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026